As of November 2024, Concord Biotech has a market cap of $2.73B. This makes Concord Biotech the world's 4237th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.75B | -4.65% |
2023 | $1.84B | - |